OBJECTIVE: Our objective was to determine if low levels of a mixture of volatile organic compounds (VOCs) and their ozone (O3) oxidation products, similar to what might be found in "sick buildings," cause nasal irritation and inflammation under controlled exposure conditions. METHODS: Healthy, nonsmoking women (n=130) completed 2-hour controlled exposures to VOCs, VOCs and O3, and a masked air "MA" control in random order at least 1 week apart. VOCs and O3 concentrations were approximately 25 mg/m and approximately 40 ppb, respectively. Nasal symptoms were rated before, during, and after exposure. Nasal lavage fluid was analyzed for polymorphonuclear cells, total protein, interleukin-6, and interleukin-8. RESULTS: We found no significant differences in symptoms or markers of nasal inflammation between exposure conditions. CONCLUSIONS: Results suggest that VOCs and their oxidation products may not cause acute nasal effects at low concentrations.
OBJECTIVE: Our objective was to determine if low levels of a mixture of volatile organic compounds (VOCs) and their ozone (O3) oxidation products, similar to what might be found in "sick buildings," cause nasal irritation and inflammation under controlled exposure conditions. METHODS: Healthy, nonsmoking women (n=130) completed 2-hour controlled exposures to VOCs, VOCs and O3, and a masked air "MA" control in random order at least 1 week apart. VOCs and O3 concentrations were approximately 25 mg/m and approximately 40 ppb, respectively. Nasal symptoms were rated before, during, and after exposure. Nasal lavage fluid was analyzed for polymorphonuclear cells, total protein, interleukin-6, and interleukin-8. RESULTS: We found no significant differences in symptoms or markers of nasal inflammation between exposure conditions. CONCLUSIONS: Results suggest that VOCs and their oxidation products may not cause acute nasal effects at low concentrations.
Authors: Vasanthi R Sunil; Robert J Laumbach; Kinal J Patel; Barbara J Turpin; Ho-Jin Lim; Howard M Kipen; Jeffrey D Laskin; Debra L Laskin Journal: Toxicol Appl Pharmacol Date: 2007-05-21 Impact factor: 4.219
Authors: Benjamin G Wu; Imran Sulaiman; Jing Wang; Nan Shen; Jose C Clemente; Yonghua Li; Robert J Laumbach; Shou-En Lu; Iris Udasin; Oanh Le-Hoang; Alan Perez; Shahnaz Alimokhtari; Kathleen Black; Michael Plietz; Akosua Twumasi; Haley Sanders; Patrick Malecha; Bianca Kapoor; Benjamin D Scaglione; Anbang Wang; Cameron Blazoski; Michael D Weiden; David M Rapoport; Denise Harrison; Nishay Chitkara; Eugenio Vicente; José M Marin; Jag Sunderram; Indu Ayappa; Leopoldo N Segal Journal: Am J Respir Crit Care Med Date: 2019-01-01 Impact factor: 21.405
Authors: Howard M Kipen; Sampada Gandhi; David Q Rich; Pamela Ohman-Strickland; Robert Laumbach; Zhi-Hua Fan; Li Chen; Debra L Laskin; Junfeng Zhang; Kiran Madura Journal: Environ Health Perspect Date: 2010-12-15 Impact factor: 9.031
Authors: Chelsea A Weitekamp; Tina Stevens; Michael J Stewart; Prakash Bhave; M Ian Gilmour Journal: Sci Total Environ Date: 2019-11-30 Impact factor: 10.753
Authors: Nancy Fiedler; Robert Laumbach; Kathie Kelly-McNeil; Paul Lioy; Zhi-Hua Fan; Junfeng Zhang; John Ottenweller; Pamela Ohman-Strickland; Howard Kipen Journal: Environ Health Perspect Date: 2005-11 Impact factor: 9.031
Authors: Philip W Rouadi; Samar A Idriss; Robert M Naclerio; David B Peden; Ignacio J Ansotegui; Giorgio Walter Canonica; Sandra Nora Gonzalez-Diaz; Nelson A Rosario Filho; Juan Carlos Ivancevich; Peter W Hellings; Margarita Murrieta-Aguttes; Fares H Zaitoun; Carla Irani; Marilyn R Karam; Jean Bousquet Journal: World Allergy Organ J Date: 2020-10-05 Impact factor: 4.084